Research ArticleAcute endotoxemia following transjugular intrahepatic stent-shunt insertion is associated with systemic and cerebral vasodilatation with increased whole body nitric oxide production in critically ill cirrhotic patients
Introduction
Acute decompensation of cirrhosis due to a precipitating illness often progresses to acute systemic hypotension which may also be associated with severe hepatic encephalopathy and multi-organ failure, as well as with high mortality rates. Moreover, these symptoms are difficult to distinguish clinically from acute liver failure, a condition often referred to as acute-on-chronic liver failure (ACLF) [1]. A small proportion of patients develops overt intracranial hypertension [2], [3]. Previous studies have shown that TIPSS results in increased cardiac output (CO) and a reduction in systemic vascular resistance (SVR) and mean arterial pressure (MAP) [4], [5]. We have previously reported deaths in four patients due to brain herniation from intracranial hypertension following insertion of a transjugular intrahepatic portosystemic stent-shunt (TIPSS) [2], [3]. These patients had advanced liver disease, uncontrolled variceal bleeding, sepsis, and renal failure. The TIPSS procedure may provide the opportunity to study the hemodynamic effects of acute portacaval shunting in patients with cirrhosis and provide clues to factors important in the pathogenesis of circulatory collapse and the hepatic encephalopathy components of ACLF.
Recent studies also point to an important role of the systemic inflammatory response in the pathogenesis of ACLF and the associated hepatic encephalopathy [6], [7], [8]. Our recent studies have suggested that patients with severe alcoholic hepatitis who progress to ACLF have markedly altered neutrophil function which is possibly mediated through high circulating endotoxin levels. Endotoxin is not only a priming agent but can also fully activate neutrophils [9], [10], [11], probably by up-regulating the NADPH oxidase assembly [11]. The highest levels of endotoxin reported in patients with liver disease are found in portal venous blood [12], [13], highlighting the importance of the bowel and altered gut permeability as the possible source of endotoxin [14]. Hence, it would be reasonable to expect that TIPSS insertion may exacerbate the existing endotoxemia which is known to induce iNOS in endothelial cells.
The aims of the present study were, therefore, to test the hypothesis that TIPSS worsens endotoxemia which increases nitric oxide production resulting in acute systemic and cerebral changes. In endothelial cell culture systems, we also wanted to determine whether incubation of the cells with patient’s plasma would alter the activity of nitric oxide synthase.
Section snippets
Methods
Studies were undertaken with the approval of the local research ethics committee, written informed consent was obtained from the next of kin of each patient, and were in accordance with the Declaration of Helsinki (1951) of the World Medical Association.
Results
Twelve patients were enrolled into the study. In two patients, placement of a reverse jugular vein catheter was not possible for technical reasons. In one other patient, the measurement of CBF failed due to technical difficulties with the automatic sampler and the mean value of CBF from the whole group was used for calculation of the brain flux in this patient. The present paper, therefore, reports the systemic data obtained from all the 12 patients but CBF data from nine patients and brain
Discussion
The most important result of our study was the observation of acute systemic and cerebral vasodilatation which was closely correlated with an increase in whole body nitric oxide production after TIPSS insertion. This resulted in exacerbation of endotoxemia and in whole body NO production but not in the arterial or brain flux of pro-inflammatory cytokines. The ex vivo experiments suggested that this increase in the rate of production of nitric oxide was associated with an increase in the
Disclaimer
The data presented in this paper are original. The only data that overlap with the previous paper are the ammonia data. Other observations from the patients described in this paper have been described before in ‘Olde Damink et al. Am J Physiol Gastrointest Liver Physiol’ and ‘Olde Damink et al. 2006;291(2):G189–94. Hepatology 2003;37(6):1277–85.’
Acknowledgements
We acknowledge gratefully the co-operation of all the medical and non-medical staff in the Intensive Care Unit of the Royal Infirmary of Edinburgh and also Dr. Stuart McLennan for help with the successful completion of the studies. We also acknowledge the contribution of Dr. V. Balasubramanium and Dr. Dipok Dhar who kindly performed the ex-vivo studies measuring NOS activity in HUVEC cell-line. Dr. Steven W.M. Olde Damink was supported on a grant from the Wellcome Trust (UK).
References (44)
- et al.
Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage
J Hepatol
(1997) - et al.
Cerebral oedema and increased intracranial pressure in chronic liver disease
Lancet
(1998) - et al.
The systemic inflammatory response syndrome in acute liver failure
Hepatology
(2000) - et al.
Infection and the progression of hepatic encephalopathy in acute liver failure
Gastroenterology
(2003) - et al.
Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow
J Hepatol
(2004) - et al.
Chronic endotoxemia reversibly alters respiratory burst activity of circulating neutrophils
J Surg Res
(1993) - et al.
Gut microflora in the pathogenesis of the complications of cirrhosis
Best Pract Res Clin Gastroenterol
(2004) - et al.
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial
Gastroenterology
(1977) - et al.
Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure
Lancet
(1999) - et al.
Determination of amino acid isotope enrichment using liquid chromatography-mass spectrometry
Anal Biochem
(1999)
Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis
Gastroenterology
The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough
Hepatology
Nitric oxide mediates the reduced vasoconstrictor response to angiotensin II in patients with preascitic cirrhosis
J Hepatol
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis
Hepatology
Mild hypothermia modifies ammonia-induced brain edema in rats after portacaval anastomosis
Gastroenterology
Cerebral hyperemia and nitric oxide synthase in rats with ammonia-induced brain edema
J Hepatol
Acute-on-chronic liver failure: pathophysiological basis of therapeutic options
Blood Purif
Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study
Hepatology
Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis
Hepatology
Dose effects of LPS on neutrophils in a whole blood flow cytometric assay of phagocytosis and oxidative burst
Cytometry
Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly
J Clin Invest
Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis
Scand J Gastroenterol
Cited by (32)
Cerebral Blood Flow and Metabolism in Hepatic Encephalopathy—A Meta-Analysis
2018, Journal of Clinical and Experimental HepatologyA pilot study of a non-invasive oral nitrate stable isotopic method suggests that arginine and citrulline supplementation increases whole-body NO production in Tanzanian children with sickle cell disease
2018, Nitric Oxide - Biology and ChemistryCitation Excerpt :A lower systemic NO synthesis was also measured in ten critically ill children with sepsis (NO synthesis rate = 1.58 ± 0.7 μmol/kg/h) and differences with our study could be related to disease pathogenesis and/or characteristics of the stable isotope methods [11]. However, two studies found similar (2.4 ± 0.6 μmol/kg/h) [12] or higher (4.3 ± 2.7 μmol/kg/h) [13] NO synthesis rates in adult patients with cirrhosis and end stage renal disease, respectively, using isotopic methods based on the intravenous administration of labelled arginine. There is currently limited information on the NO synthesis rates in pediatric populations.
Inflammation and portal hypertension - The undiscovered country
2014, Journal of HepatologyCitation Excerpt :There is indirect evidence in humans for gut-derived bacteria exacerbating systemic circulatory dysfunction in cirrhosis. Patients with advanced cirrhosis demonstrate increased systemic NO production and endotoxinemia following TIPS insertion [62]. Plasma from these patients, when incubated with HUVEC cells, leads to decreased eNOS activity but increased iNOS activity, suggesting that portal venous bacterial products cause increased systemic NO production and circulatory dysfunction.
Changes in cerebral blood flow after transjugular intrahepatic portosystemic shunt can help predict the development of hepatic encephalopathy: An arterial spin labeling MR study
2012, European Journal of RadiologyCitation Excerpt :On the one hand, increased CBFs were found widely in the brain regions and over half of cirrhotic patients (66.7%, 6/9) following TIPS were of global increased CBFs. These findings were consistent with the previous reports on patients after TIPS [8]. Also, our results were similar with measurements of patients after portacaval shunt operation [5] and rats with portacaval shunt-induced hyperammonemia [17], in which CBFs were reported to increase.
Acute-on chronic liver failure
2012, Journal of HepatologyCitation Excerpt :In a recent study, the acute effect of insertion of a transjugular intrahepatic shunt, which is known to induce endotoxemia, was studied in patients with cirrhosis. The study demonstrated that TIPSS-induced endotoxemia led to an increase in the rate of production of nitric oxide, which was associated with endothelial dysfunction and increased cerebral blood flow supporting the hypothesis that multiple hits and brain swelling is a feature of ACLF [115] (Fig. 5). However, the insertion of TIPSS in relatively well cirrhotics without hepatic encephalopathy undergoing TIPSS was not associated with a change in cerebral blood flow, stressing the pathophysiologically distinct nature of ACLF from otherwise stable cirrhosis [116].